News Releases

Cancer prevention expert Anne McTiernan appointed to clinical trials advisory panel - Fred Hutchinson Cancer Research Center

Panel will provide expertise on trial selection, design and implementation
Anne McTiernan
Anne McTiernan, M.D., Ph.D., is a member of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center. Photo credit: Fred Hutch file

SEATTLE – March 31, 2014 – Anne McTiernan, M.D., Ph.D., a Fred Hutchinson Cancer Research Center breast and colorectal cancer prevention researcher, is among 10 people recently appointed to the Patient-Centered Outcomes Research Institute’s inaugural Advisory Panel on Clinical Trials.

McTiernan, a member of the Fred Hutch Public Health Sciences Division, is an internist and epidemiologist whose research focuses on identifying ways to prevent new or recurrent breast and colorectal cancer with a particular focus on physical activity, weight control, and chemoprevention.

Members of the Advisory Panel on Clinical Trials will provide expertise on the design and implementation of randomized, controlled trials. Topics warranting their input include selection of appropriate patient-centered outcomes, informed consent of study participants, periodic evaluations of PCORI’s clinical trial portfolio, and the readiness of trial results for dissemination.

The panelists and four alternates, comprising biostatisticians, epidemiologists, patients, patient advocates, and bioethics, were selected from 231 applicants. The panel will convene for its first meeting May 1 in Washington, D.C. 

Kristen Woodward